...
首页> 外文期刊>European review for medical and pharmacological sciences. >Denitrosylation of nNOS induced by cerebral ischemia-reperfusion contributes to nitrosylation of CaMKII and its inhibition of autophosphorylation in hippocampal CA1
【24h】

Denitrosylation of nNOS induced by cerebral ischemia-reperfusion contributes to nitrosylation of CaMKII and its inhibition of autophosphorylation in hippocampal CA1

机译:通过脑缺血再灌注诱导的NNOS的脱氮化有助于CAMKII的亚硝基化,并抑制海马CA1中的自磷酸化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The aim of this study is to investigate the relation between CaMKII S-nitrosylation and its activation, as well as the underlying mechanism, after global cerebral ischemia-reperfusion. MATERIALS AND METHODS: The rat model of cerebral ischemia-reperfusion was established by four-vessel occlusion of 15 min and reperfusion of different times. nNOS inhibitor 7-nitroindazole (7-NI), exogenous nitric oxide donor GSNO (nitrosoglutathione), or N-methyl-D-aspartate receptor (NMDAR) antagonist MK-801 were administered before ischemia. The expressions of S-nitrosylation and phosphorylation of CaMKII and nNOS were detected by biotin switch assay, immunoblotting, and immunohistochemical staining after cerebral ischemia-reperfusion. The survival of hippocampal CA1 pyramidal cells after administration of the three drugs was examined by cresyl violet staining. RESULTS: Following cerebral ischemia-reperfusion, the S-nitrosylation of CaMKII was increased, accompanied by a decrease of phosphorylation, suggesting a decrease of activity (p0.05). Meanwhile, the phosphorylation and S-nitrosylation of nNOS were notably decreased at the same time point (p0.05). The administration of 7-NI, GSNO, and MK-801 increased the S-nitrosylation and phosphorylation of nNOS, leading to the attenuation of increased S-nitrosylation and decreased autophosphorylation of CaMKII after cerebral ischemia-reperfusion (p0.05). Administration of MK-801, GSNO, and 7-NI significantly decreased the neuronal damage in rat hippocampal CA1 caused by cerebral ischemia-reperfusion (p0.05). CONCLUSIONS: After cerebral ischemia-reperfusion, the decrease of autophosphorylation of CaMKII regulated by its S-nitrosylation may be due to the denitrosylation of nNOS and subsequent NO production. Increasing the phosphorylation of CaMKII by nNOS inhibitor, exogenous NO donor or NMDA receptor antagonist exerted neuroprotective effects against cerebral ischemia-reperfusion injury.
机译:目的:本研究的目的是探讨Camkii S-亚硝基化物质与其活化的关系,以及全球脑缺血再灌注后的潜在机制。材料和方法:通过四血管闭塞建立了脑缺血再灌注的大鼠模型,闭塞15分钟并再灌注不同的时间。 NNOS抑制剂7-硝基吲唑(7-NI),外源一氧化氮供体GSNO(亚硝葡萄球菌),或N-甲基-D-天冬氨酸受体(NMDAR)拮抗剂MK-801被施用在缺血前。通过生物素开关测定,免疫印迹和免疫组化染色在脑缺血再灌注后检测S-亚硝基化和钙化和磷酸化的表达。通过羰基紫染色检查三种药物后海马CA1金字塔孔细胞的存活。结果:在脑缺血再灌注后,CAMKII的S-亚硝基化增加,伴有磷酸化降低,表明活性降低(P <0.05)。同时,NNO的磷酸化和S-亚硝基化在同一时间点显着降低(P <0.05)。 7-Ni,GSNO和MK-801的给药增加了NNOS的S-亚硝基化和磷酸化,导致脑缺血再灌注后增加了S-亚硝基化的衰减并降低了CAMKII的自磷酸化(P <0.05)。 MK-801,GSNO和7-NI的给药显着降低了大鼠海马CA1中的神经元损伤,由脑缺血再灌注引起的(P <0.05)。结论:在脑缺血再灌注后,其S-亚硝基化患者对CAMKII的自磷酸化减少可能是由于NNOS的脱氮化和随后的生产。通过NNOS抑制剂增加CAMKII的磷酸化,外源性没有供体或NMDA受体拮抗剂对脑缺血再灌注损伤的神经保护作用施加了神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号